EURONLABS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: KS
Kenneth Sanders1987
Chairman of the board: WA
Waqas Aziz Malik1984
Years since formation: 1 year; since Apr 10, 2024
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 30,000; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
KS Kenneth Sanders 1987	Managing Director/CEO	-

Board

Name	Role	Shares
WA Waqas Aziz Malik 1984	Chairman	-
KS Kenneth Sanders 1987	Board Member	-
NH Nils Haga 1962	Board Member	-

Others

Name	Role	Shares
M MR ØKONOMI AS	Accountant	-

Last update: May 30, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
E EURON VENTURE GROUP AS	Ordinary shares	30,000	100 %

Last update: Jun 2, 2025

Group structure

EURON VENTURE GROUP AS
Total operating income 2023: NOK 305,931
Operating profit 2023: NOK -1,521,404
Employees: 0

Financials

in NOK

No available data

EURONLABS AS933 101 703

EURONLABS AS

Keywords

Organization

Ownership

Management

Management / administration

Board

Others

Ownership

Company shareholders

Group structure

Financials

Classification